Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype
J. Clin. Invest. Pal Kaposi-Novak, et al. 116:1582
doi:10.1172/JCI27236 [Go to this article.]

Figure 6
Association between the different clinicopathological variables and the Met+ and Met HCC subsets defined by hierarchical cluster analysis of the LEC samples. Kaplan-Meier plot (A) and log-rank statistics demonstrate the difference in the overall survival between HCC patients from the Met+ and from the Met groups. (B and C) Bar graphs represent vascular invasion rate (B) and average MVD (C) in HCC samples from Met+ and Met sets. MVD was determined by quantitative analysis of CD34+ vascular features. (D and E) Microscope images show CD34 staining of endothelial cells in representative samples from Met+ (D) and Met (E) tumor sets. Pictures were taken with ×200 original magnification.